Letter from the Editor

Contributed by:

Taren Grom, Editor

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Times Are a Changing…

In speaking with a dozen-plus agency CEOs and presidents for this month’s cover story, it became apparent that these industry leaders are in fact leading the industry in many respects. They are like orchestra conductors, tasked with making sure their talented creative teams achieve harmonic synchronicity amid a cacophony of divergent movements.

They are tuned in to advancements being made in high-science brands, and in some cases are sitting at the table with science leaders and innovators.

They are ahead of the curve on many of the current trends, having already put in place departments or teams to begin strategizing around technology advancements such as chatbots and voice assistants and new channel opportunities that go beyond Facebook and Google. For example, the rise of conversational artificial intelligence (AI) has changed the search landscape. Analysts say by 2020, 50% of search queries will be voice searches. Healthcare agencies need to be one step ahead, and many of them already have linguistic teams in place to manage complex algorithms and create authentic, credible, and compliant messaging.

Additionally, with YouTube now being the second-largest search engine and the No. 1 search app with more than 4 billion searches per month for content in the United States alone, marketers need to think beyond static images and craft communications that translate into live video. Digital Marketing World has predicted that by 2021, 13% of all Internet traffic will consist of live video. And that is just one chunk of the whole video gamut. With almost every major social media platform now supporting live video streaming, it is only expected to soar in 2020.
The implications are far-reaching. Video could be the answer to the age-old issue of compliance and address health literacy in a way that has yet to be solved.

Agency leaders are being called on to make their organizations more agile in response to client requests even as current talent pools are stretched to capacity.

Many big consultancies are touting the advantages of agile organizations, which is defined as being quick to respond to changes in the marketplace or environment. While agility can mean something different for every single client, agencies are adapting and applying the same agile processes they use for pitches to the work they do every day for clients.

Clients want “wow” campaigns that reflect current social norms and attitudes. Cultural influences are testing the courage of marketers and they are stepping up in big and small ways. Healthcare advertising is beginning to reflect the real people and patient populations of those who are actually using the medications being prescribed.

Every agency CEO/president is hypercognizant of the bottom line and some agencies are adopting different models or even changing their calling cards to reflect a broader take on the services they provide beyond traditional advertising tactics.

It’s an exciting time to be in healthcare advertising — boundaries are being erased and creativity is being championed.

Taren Grom, Editor


Their word…

Denise Myshko
Managing Editor

Biopharma companies are teaming up with academia and patient groups to translate promising candidates to new therapies.

Robin Robinson
Senior Editor

As partnerships between pharma and health tech companies increase, so do the opportunities for creating better health outcomes.

Kim Ribbink
Features Editor

Some exciting developments with big data are emerging for the pharmaceutical industry, such as predictive modeling.


Coming in October

Virtual Health
Relationship Marketing
Gender Parity: Update
Artificial Intelligence
Patient Solutions



The forum for the industry executive

Volume 19 • Number 8
Publisher Lisa Banket
Editor Taren Grom
Creative Director Marah Walsh

Managing Editor
Denise Myshko

Senior Editor
Robin Robinson

Features Editor
Kim Ribbink

Design Associate
Ariel Medel

Director of Sales
Cathy Tracy

National Account Manager
Suzanne Besse

Webcast Network Producer
Daniel Limbach

Circulation Assistant
Kathy Deiuliis

Copyright 2019
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Nineteen, Number Eight

PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by ­Pharma­­Linx LLC, P.O. Box 327, Titusville, NJ 08560. ­Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.

Postmaster: Send address changes to PharmaVOICE, P.O. Box 292345, Kettering, OH 45429-0345.

PharmaVoice Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.

Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: tgrom@pharmavoice.com.

Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: mwalsh@pharmavoice.com.

Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change.

Advertising in PharmaVoice: To advertise in Pharma­­Voice please contact our Advertising ­Department at P.O. Box 327, Titusville, NJ 08560, or ­telephone us at 609.730.0196. E-mail: lbanket@pharmavoice.com.

Letters …
Send your letters to feedback@pharma­voice.com. Please include your name, title, company, and business phone number. Letters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLC.

Posted in:

Post a Comment

You must be logged in to post a Comment.